cu peptide FAQ

You can't. Not reliably. Freezing reconstituted peptide solutions causes ice crystal formation that shears peptide bonds and denatures the copper complex. Lyophilisation (freeze-drying) protects against this, but home freezers don't provide the controlled environment needed for re-lyophilisation. Adding additional bacteriostatic water doesn't extend stability; it dilutes the peptide without addressing oxidative degradation. The 28-day window at 2–8°C is a hard constraint based on copper peptide chemistry. If your study duration exceeds four weeks, reconstitute smaller aliquots on a rolling basis rather than attempting to preserve a single large batch.

Administer the missed dose as soon as you remember, then resume the regular schedule from that point forward. If you're more than 8 hours past the scheduled time, skip the missed dose and continue with the next scheduled administration. Do not double-dose. Missing one dose in a multi-week protocol has minimal impact on cumulative results. The receptor signalling cascade doesn't reset to zero; it tapers gradually. The risk with doubling up is receptor desensitisation. Flooding the system with twice the normal peptide concentration can trigger negative feedback loops that temporarily suppress the pathways you're trying to activate.

Discard it immediately. AHK-Cu in solution should be clear to faintly blue-tinted (from the copper ion). Cloudiness indicates protein aggregation or bacterial contamination; discolouration (yellow, brown, green) suggests oxidative degradation. Using degraded peptide isn't just ineffective. Oxidised copper peptides can generate reactive oxygen species that damage tissue rather than promoting repair. This is precisely why our Cognitive Function formulations include antioxidant co-factors. Copper's catalytic activity is therapeutic when controlled but destructive when unregulated.

Request a Certificate of Analysis (CoA) with HPLC data showing the peptide's amino-acid composition and molecular weight before ordering. Reputable suppliers provide CoAs upon request—if a supplier refuses or cannot produce verification documentation, the product's molecular identity cannot be confirmed. The absence of amino-acid sequencing data means you cannot verify whether 'AHK Copper' actually contains alanine-histidine-lysine or if the listing is mislabeled. Real Peptides includes batch-specific CoAs with every peptide shipment, showing exact amino-acid sequencing and copper chelation verification through mass spectrometry.

Verify the CAS registry number and catalog specifications before ordering. If both listings show the same molecular weight (approximately 404 Da), amino acid sequence (Ala-His-Lys), and copper coordination, they are the same peptide and ordering both wastes budget. Contact the supplier directly and request clarification—reputable vendors will confirm the duplication and consolidate the order. If the supplier insists they are different compounds without providing distinguishing analytical data, that's a red flag indicating insufficient quality control or deliberate catalog padding.

Check three variables: peptide concentration, copper coordination, and media composition. Effective concentrations range from 1–50 μM depending on assay endpoint—lower concentrations suit proliferation assays, higher concentrations are used for ECM gene expression studies. Verify the peptide was stored correctly and hasn't exceeded its reconstituted shelf life. Finally, confirm your culture media doesn't contain EDTA or other chelating agents that strip copper from the peptide, rendering it inactive. Switch to EDTA-free media and supplement fresh peptide every 48 hours for extended assays.

This is correct—Copper Tripeptide-1 is the INCI regulatory name for AHK-Cu and does not indicate a different compound. Cosmetic ingredient databases and some international suppliers use Copper Tripeptide-1 to comply with labeling regulations that require expanded chemical names rather than abbreviations. Cross-check the molecular weight (should be approximately 340 Da) and confirm the amino-acid sequence is Ala-His-Lys. If both match, the peptide is AHK-Cu regardless of the name on the label. The regulatory designation exists for compliance, not to distinguish molecular variants.

Proceed with the order—they are the same molecule. The naming variation does not indicate structural differences, formulation changes, or activity profile variations. Verify the supplier provides the correct amino-acid sequence (Ala-His-Lys) and copper chelation in their product specifications or CoA. If documentation confirms the tripeptide structure and copper binding, the peptide meets the research protocol requirements whether the listing uses AHK-Cu, AHK Copper, or Copper Tripeptide-1. The clinical literature referencing AHK-Cu and commercial products labeled AHK Copper describe identical peptide complexes.

Copper-peptide complexes can range from off-white to pale blue depending on copper oxidation state and counterion composition. A blue tint typically indicates Cu²⁺ in a specific coordination geometry and is not inherently problematic. However, reconstitute a small aliquot and measure absorbance at 280 nm (peptide bond) and 600–650 nm (copper d-d transition). If the 600 nm peak is disproportionately high relative to the peptide peak, the sample may contain excess free copper ions. Request a CoA with copper quantification data to confirm the 1:1 peptide-to-copper ratio.

Recognize they are distinct peptides with different amino-acid sequences and non-interchangeable activities. AHK-Cu contains alanine-histidine-lysine; GHK-Cu contains glycine-histidine-lysine. That single amino-acid substitution (alanine vs. glycine at the first position) changes receptor binding affinity and downstream signaling effects. GHK-Cu has significantly more published clinical data for collagen synthesis and wound healing, making it the better-characterized choice for general collagen research. AHK-Cu shows specificity for certain matrix metalloproteinase inhibition pathways. Choose based on the specific cellular pathway you're investigating, not on naming similarity or the assumption that all copper peptides function identically.